Biotech · Private company · Seattle, WA, US
Orlance, Inc.
Track this companyFree. Adds Orlance, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards10
- Enhanced Seasonal Influenza Vaccine Targeting Variable and Conserved AntigensFiscal year 2026 · $1MNIH RePORTER 4R44AI186932-02 · fetched Nov 12, 2026
- Therapeutic nucleic acid vaccine for chronic hepatitis B in HIV/HBV co-infected individualsFiscal year 2026 · $298.8KNIH RePORTER 5R41AI195068-02 · fetched Nov 12, 2026
- Therapeutic nucleic acid vaccine for chronic hepatitis B in HIV/HBV co-infected individualsFiscal year 2025 · $300KNIH RePORTER 1R41AI195068-01 · fetched Nov 12, 2026
- Gene Gun-delivered RNA vaccines.Fiscal year 2025 · $300KNIH RePORTER 5R43AI181303-02 · fetched Nov 12, 2026
- Clinic-Ready MACH-1 Gene Gun for delivery of a universal influenza DNA vaccineFiscal year 2025 · $977.3KNIH RePORTER 5R44AI179440-03 · fetched Nov 12, 2026
- Gene Gun-delivered RNA vaccines.Fiscal year 2024 · $300KNIH RePORTER 1R43AI181303-01A1 · fetched Nov 12, 2026
- Enhanced Seasonal Influenza Vaccine Targeting Variable and Conserved AntigensFiscal year 2024 · $300KNIH RePORTER 1R44AI186932-01 · fetched Nov 12, 2026
- Next Generation Gene-Gun Delivered DNA and RNA Immunotherapeutic Vaccines for Melanoma.Fiscal year 2024 · $200KNIH RePORTER 5R43CA281585-02 · fetched Nov 12, 2026
- Universal Influenza A/B VaccineFiscal year 2024 · $1MNIH RePORTER 5R44AI153011-04 · fetched Nov 12, 2026
- Clinic-Ready MACH-1 Gene Gun for delivery of a universal influenza DNA vaccineFiscal year 2024 · $990.3KNIH RePORTER 5R44AI179440-02 · fetched Nov 12, 2026